13,598 Shares in Genpact Limited (NYSE:G) Bought by Sherbrooke Park Advisers LLC

Sherbrooke Park Advisers LLC acquired a new position in Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 13,598 shares of the business services provider's stock, valued at approximately $584,000.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Atlas Capital Advisors Inc. raised its holdings in shares of Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares during the last quarter. Stifel Financial Corp raised its holdings in shares of Genpact by 1.0% in the fourth quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider's stock worth $1,324,000 after acquiring an additional 291 shares during the last quarter. CIBC Asset Management Inc lifted its stake in shares of Genpact by 5.5% during the 4th quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider's stock worth $244,000 after purchasing an additional 297 shares during the period. UMB Bank n.a. lifted its stake in shares of Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after purchasing an additional 433 shares during the period. Finally, OneAscent Wealth Management LLC lifted its stake in shares of Genpact by 5.5% during the 4th quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider's stock worth $360,000 after purchasing an additional 439 shares during the period. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Needham & Company LLC dropped their target price on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Mizuho upped their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Robert W. Baird decreased their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $50.71.

Insider Transactions at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nicholas C. Gangestad purchased 2,000 shares of Genpact stock in a transaction dated Tuesday, May 13th. The shares were bought at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the transaction, the director now directly owns 2,000 shares of the company's stock, valued at approximately $87,940. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Company insiders own 3.07% of the company's stock.

Genpact Trading Down 0.5%

G stock traded down $0.20 during trading on Thursday, reaching $43.47. 333,736 shares of the stock traded hands, compared to its average volume of 1,581,868. The business's 50 day moving average price is $47.69 and its 200-day moving average price is $47.25. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The firm has a market capitalization of $7.60 billion, a PE ratio of 15.31, a P/E/G ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The business had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the previous year, the business posted $0.73 EPS. The business's quarterly revenue was up 7.4% on a year-over-year basis. As a group, sell-side analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.